23 December 2018

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

23 December 2018 | n=34

  1. McGowan I, Wilkin T, Landovitz RJ, Wu C, et al.
    The pharmacokinetics, pharmacodynamics, and mucosal responses to maraviroc-containing PrEP Regimens in Men who have Sex with Men.
    AIDS 2018.

  2. Fatukasi TV, Edmonds A, Gustafson DR, Cole SR, et al.
    Prevalence and 1-year incidence of frailty among women with and without HIV in the Women's Interagency HIV Study.
    AIDS 2019;33:357-359.

  3. Rajasuriar R, Palmer C, Abdel-Mohsen M, Kamaruzzaman SB, et al.
    Integrative biomarkers of biologic aging in HIV.
    AIDS 2019;33:345-347.

  4. .
    Nucleoside reverse transcriptase inhibitor backbones and pregnancy outcomes.
    AIDS 2019;33:295-304.

  5. Moso MA, Anderson JL, Adikari S, Gray LR, et al.
    HIV latency can be established in proliferating and nonproliferating resting CD4+ T cells in vitro: implications for latency reversal.
    AIDS 2019;33:199-209.

  6. De Cock KM, Barker JL, Baggaley R, El Sadr WM, et al.
    Where are the positives? HIV testing in sub-Saharan Africa in the era of test and treat.
    AIDS 2019;33:349-352.

  7. Cuadros DF, Li J, Mukandavire Z, Musuka GN, et al.
    Towards UNAIDS Fast-Track goals: targeting priority geographic areas for HIV prevention and care in Zimbabwe.
    AIDS 2019;33:305-314.

  8. McGowan I, Wilkin T, Landovitz RJ, Wu C, et al.
    The pharmacokinetics, pharmacodynamics, and mucosal responses to maraviroc-containing pre-exposure prophylaxis regimens in MSM.
    AIDS 2019;33:237-246.

  9. Guha D, Mukerji SS, Chettimada S, Misra V, et al.
    CSF extracellular vesicles and neurofilament light protein as biomarkers of CNS injury in HIV-infected patients on antiretroviral therapy.
    AIDS 2018.

  10. Tomita A, Vandormael A, Barnighausen T, Phillips A, et al.
    Socio-behavioural and community predictors of unsuppressed viral load: multi-level results from a hyper-endemic rural South African population.
    AIDS 2018.

  11. Pham DT, Nguyen DTT, Nguyen TA, Tran CV, et al.
    AIDS Res Hum Retroviruses 2018.

  12. Laeyendecker O, Gray R, Grabowski M, Reynolds S, et al.
    Validation of the Limiting Antigen Avidity Assay to Estimate Level and Trends in HIV Incidence in an A/D epidemic in Rakai, Uganda.
    AIDS Res Hum Retroviruses 2018.

  13. Irias SDF, Torres MKS, Avelino MES, Santos MB, et al.
    HIV-1 transmitted drug resistance mutations in recently diagnosed antiretroviral-naive patients in Belem, Para, Northern of Brazil.
    AIDS Res Hum Retroviruses 2018.

  14. Soria JI, Mugruza R, Levine M, Leon SR, et al.
    Pretreatment HIV drug resistance and virologic outcomes to first-line antiretroviral therapy in Peru.
    AIDS Res Hum Retroviruses 2018.

  15. Namuniina A, Lutwama F, Biribawa VM, Kizza D, et al.
    Field performance of PIMA Point-of-Care Machine for CD4 Enumeration Under a Mobile HIV Counseling and Testing Program in Remote Fishing Communities of Lake Victoria, Uganda.
    AIDS Res Hum Retroviruses 2018.

  16. Togo J, Maiga AI, Sylla M, Kone B, et al.
    Evaluation of Two HIV Rapid Diagnostic Tests in a Context of Strains' Genetic Diversity in Mali.
    AIDS Res Hum Retroviruses 2018.

  17. Gilbert L, Wang X, Deiss R, Okulicz J, et al.
    Herpes Zoster Rates Continue to Decline in People Living with HIV but Remain Higher than Rates Reported in the General US Population.
    Clin Infect Dis 2018.

  18. Jallow S, Agosti Y, Kgagudi P, Vandecar M, et al.
    Impaired transplacental transfer of respiratory syncytial virus (RSV) neutralizing antibodies in HIV-infected compared to HIV-uninfected pregnant women.
    Clin Infect Dis 2018.

  19. Benmassaoud A, Nitulescu R, Pembroke T, Halme AS, et al.
    Liver-related events in HIV-infected persons with occult cirrhosis.
    Clin Infect Dis 2018.

  20. Joseph SB, Kincer LP, Bowman NM, Evans C, et al.
    HIV-1 RNA Detected in the CNS after Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.
    Clin Infect Dis 2018.

  21. Imaz A, Niubo J, Cottrell ML, Perez E, et al.
    Seminal Tenofovir Concentrations, Viral Suppression, and Semen Quality With Tenofovir Alafenamide Compared with Tenofovir Disoproxil Fumarate (Spanish HIV/AIDS Research Network, PreEC/RIS 40).
    Clin Infect Dis 2018.

  22. Prat LI, Roccarina D, Lever R, Lombardi R, et al.
    Aetiology and severity of liver disease in HIV positive patients with suspected NAFLD: lessons from a cohort with available liver biopsies.
    J Acquir Immune Defic Syndr 2018.

  23. Lemoine M, Assoumou L, De Wit S, Girard PM, et al.
    Diagnostic accuracy of noninvasive markers of steatosis, NASH and liver fibrosis in HIV-monoinfected individuals at-risk of non-alcoholic fatty liver disease (NAFLD): results from the ECHAM study.
    J Acquir Immune Defic Syndr 2018.

  24. Willie TC, Stockman JK, Keene DE, Calabrese SK, et al.
    Social networks and its impact on women's awareness, interest, and uptake of HIV pre-exposure prophylaxis (PrEP): Implications for women experiencing intimate partner violence.
    J Acquir Immune Defic Syndr 2018.

  25. Davis NL, Corbett A, Kaullen J, Nelson JAE, et al.
    Antiretroviral drug concentrations in breastmilk, maternal HIV viral load, and HIV transmission to the infant: results from the BAN study.
    J Acquir Immune Defic Syndr 2018.

  26. Poizot-Martin I, Rosenthal E, Gilbert C, Cano CE, et al.
    Nadir CD4 is negatively associated with antinuclear antibody detection in HCV/HIV coinfected patients.
    J Acquir Immune Defic Syndr 2018.

  27. Gosset A, Protopopescu C, Larmarange J, Orne-Gliemann J, et al.
    Retention in care trajectories of HIV-positive individuals participating in a universal test and treat programme in rural South Africa (ANRS 12249 TasP trial).
    J Acquir Immune Defic Syndr 2018.

  28. Martinez de Tejada B.
    Birth Defects Following Exposure to Efavirenz-Based Antiretroviral Therapy at Conception/First Trimester of Pregnancy: A Multi-Cohort Analysis.
    J Acquir Immune Defic Syndr 2018.

  29. Cooley SA, Strain JF, Beaumont H, Boerwinkle AH, et al.
    Tau Positron Emission Tomography Binding Is Not Elevated in HIV-Infected Individuals.
    J Infect Dis 2018.

  30. Mabvakure BM, Scheepers C, Garrett N, Abdool Karim S, et al.
    Positive selection at key residues in the HIV Envelope distinguishes broad and strain-specific plasma neutralizing antibodies.
    J Virol 2018.

  31. Bouvin-Pley M, Beretta M, Moreau A, Roch E, et al.
    Evolution of the Envelope Glycoprotein of HIV-1 Clade B towards Higher Infectious Properties over the Course of the Epidemic.
    J Virol 2018.

  32. Balasubramaniam M, Zhou J, Addai A, Martinez P, et al.
    PF74 Inhibits HIV-1 Integration by Altering The Composition of the Preintegration Complex.
    J Virol 2018.

  33. Urano E, Timilsina U, Kaplan JA, Ablan S, et al.
    J Virol 2018.

  34. Ungerleider N, Jain V, Wang Y, Maness NJ, et al.
    Comparative analysis of gammaherpesvirus circRNA repertoires: conserved and unique viral circRNAs.
    J Virol 2018.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

10 June 2019

03 June 2019

27 May 2019

20 May 2019

13 May 2019

23 December 2018

Multidisciplinary Journal Club

  1. .
    Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial.
    Lancet. 2018 Dec 4. pii: S0140-6736(18)32823.

  2. Magill SS, O'Leary E, Janelle SJ, Thompson DL, et al.
    Changes in Prevalence of Health Care-Associated Infections in U.S. Hospitals.
    N Engl J Med. 2018;379:1732-1744.

  3. Carnicelli AP, De Caterina R, Halperin JL, Renda G, et al.
    Edoxaban for the Prevention of Thromboembolism in Patients with AtrialFibrillation and Bioprosthetic Valves.
    Circulation. 2017 Feb 16. pii: CIRCULATIONAHA.116.026714.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016